Evidence map›Paper›PMID 35851804›Full record

ArticleJournal of cell science2022

A new mechanism of fibronectin fibril assembly revealed by live imaging and super-resolution microscopy.

Darshika Tomer, Cecilia Arriagada, Sudipto Munshi, Brianna E Alexander, Brenda French, Pavan Vedula, Valentina Caorsi, Andrew House, Murat Guvendiren, Anna Kashina and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fibronectin matrix assembly at a glance.Journal of cell science · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Darshika TomerDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers Biomedical, and Health Sciences, 185 South Orange Ave, Newark, NJ 07103, USA.
Cecilia ArriagadaDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers Biomedical, and Health Sciences, 185 South Orange Ave, Newark, NJ 07103, USA.ORCID 0000-0002-5351-2240
Sudipto MunshiCenter for Translational Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA.
Brianna E AlexanderDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers Biomedical, and Health Sciences, 185 South Orange Ave, Newark, NJ 07103, USA.
Brenda FrenchCenter for Translational Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA.
Pavan VedulaDepartment of Biomedical Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
Valentina CaorsiAbbelight, 191 Avenue Aristide Briand, 94230 Cachan, France.
Andrew HouseOtto H. York Chemical and Materials Engineering, Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Murat GuvendirenOtto H. York Chemical and Materials Engineering, Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Anna KashinaDepartment of Biomedical Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-0243-6866
Jean E SchwarzbauerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544-1014, USA.
Sophie AstrofDepartment of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers Biomedical, and Health Sciences, 185 South Orange Ave, Newark, NJ 07103, USA.ORCID 0000-0001-9338-9083
Rutgers, The State University of New Jersey · USNew Jersey Institute of Technology · USThomas Jefferson University · USUniversity of Pennsylvania · USPrinceton University · US

Funding

Regulation of cell migration by nucleotide coding sequence and arginylationR35GM122505 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Anna S Kashina · 2017 to 2026
$6.2M
Role of integrin a5 in the development of aortic arch arteries.R01HL103920 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ASTROF, SOPHIE · 2010 to 2024
$5.7M
Role of fibronectin in the morphogenesis of the cardiac outflow tractR01HL134935 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI Sophie Astrof · 2017 to 2026
$2.2M
Identification of compensatory mechanisms to rescue aortic arch artery defectsR01HL158049 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ASTROF, SOPHIE · 2022 to 2025
$1.9M
Fibronectin-dependent mechanisms governing the assembly of a definitive extracellular matrixR01AR073236 · NIAMS · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 2018 to 2022
$1.7M
Generation of novel Fn1-fluorescent fusion proteins in vivo for the investigation of cell_ECM dynamics in real time.R21OD025323 · OD · THOMAS JEFFERSON UNIVERSITY · PI ASTROF, SOPHIE · 2018 to 2019
$433k
Regulation of Fibronectin expression in the neural crest during vascular morphogenesisF31HL151046 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALEXANDER, BRIANNA · 2020 to 2022
$309k
NHLBI NIH HHS F31 HL151046NHLBI NIH HHS R01 HL103920NHLBI NIH HHS R01 HL134935NHLBI NIH HHS R01 HL158049NIAMS NIH HHS R01 AR073236NIGMS NIH HHS R35 GM122505NIH HHS R21 OD025323
6 · The paper itself

Abstract

Fibronectin (Fn1) fibrils have long been viewed as continuous fibers composed of extended, periodically aligned Fn1 molecules. However, our live-imaging and single-molecule localization microscopy data are inconsistent with this traditional view and show that Fn1 fibrils are composed of roughly spherical nanodomains containing six to eleven Fn1 dimers. As they move toward the cell center, Fn1 nanodomains become organized into linear arrays, in which nanodomains are spaced with an average periodicity of 105±17 nm. Periodical Fn1 nanodomain arrays can be visualized between cells in culture and within tissues; they are resistant to deoxycholate treatment and retain nanodomain periodicity in the absence of cells. The nanodomain periodicity in fibrils remained constant when probed with antibodies recognizing distinct Fn1 epitopes or combinations of antibodies recognizing epitopes spanning the length of Fn1. Treatment with FUD, a peptide that binds the Fn1 N-terminus and disrupts Fn1 fibrillogenesis, blocked the organization of Fn1 nanodomains into periodical arrays. These studies establish a new paradigm of Fn1 fibrillogenesis. This article has an associated First Person interview with the first author of the paper.

Indexed as

FibronectinsMicroscopyEpitopesExtracellular MatrixPeptidesEpitopesFibronectinsPeptidesFibrilFibrillogenesisFibronectinLive imagingSuper-resolution microscopy

Identifiers

PMID35851804
PMCPMC9481930
OpenAlexW4285798974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.